港股異動 | 農夫山泉(9633.HK)漲5.47% 獲納入MSCI新興市場指數
格隆匯2月16日丨農夫山泉(9633.HK)漲5.47%,報65.6港元,總市值7378億港元。明晟公司(MSCI)此前公佈今年二月的季度指數審閲結果,新增23只個股到MSCI ACWI指數, 新納入到MSCI新興市場指數的前三隻個股為美的集團、金龍魚(益海嘉裏)、農夫山泉。 中金報吿表示,南下資金持續加倉港股優質資產,有望整體抬升港股必選消費板塊市盈率水平,上調農夫山泉目標價42%至59港元,因其賽道優、格局好、公司競爭力突出。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.